Development and Pharmacokinetics of Galactosylated Poly-L-Glutamic Acid as a Biodegradable Carrier for Liver-Specific Drug Delivery
- 1 January 1996
- journal article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 13 (6), 880-884
- https://doi.org/10.1023/a:1016053128569
Abstract
Purpose. A biodegradable carrier for the liver-specific delivery of drugs was developed using poly-L-glutamic acid (PLGA) modified with galactose (galactosylated PLGA or Gal-PLGA), and its feasibility was investigated in mice. Methods. 111In-PLGA and 111In-Gal-PLGAs were injected in mice and their distribution and biodegradation properties were studied. Results. After intravenous injection, 111In-PLGA was rapidly eliminated from the plasma and recovered mainly in the kidneys and urine. Approximately 15% of the dose was recovered in the liver, predominantly in the nonparenchymal cells. 111In-Gal-PLGAs were taken up by the liver parenchymal cells. Derivatives having 16 or more galactose residues were taken up by the liver to a higher extent (>60% of the dose). The hepatic clearance of 111n-Gal-PLGAs correlated with their number of galactose residues. 111In-Gal18-PLGA was degraded into low-molecular weight products in the liver. Conclusions. The advantageous in vivo properties of Gal-PLGA as a liver-specific biodegradable carrier of drugs were demonstrated in mice.Keywords
This publication has 14 references indexed in Scilit:
- Macromolecular drug carrier systems in cancer chemotherapy: macromolecular prodrugsCritical Reviews in Oncology/Hematology, 1995
- Design for Cell-Specific Targeting of Proteins Utilizing Sugar-Recognition Mechanism: Effect of Molecular Weight of Proteins on Targeting EfficiencyPharmaceutical Research, 1995
- Targeted delivery of human recombinant superoxide dismutase by chemical modification with mono- and polysaccharide derivatives.1992
- Therapeutic effects of superoxide dismutase derivatives modified with mono- or polysaccharides on hepatic injury induced by ischemia/reperfusionBiochemical and Biophysical Research Communications, 1992
- A NEW RADIOCHEMICAL METHOD TO DETERMINE THE STABILITY-CONSTANTS OF METAL-CHELATES ATTACHED TO A PROTEIN1990
- Disposition and Tumor Localization of Mitomycin C–Dextran Conjugates in MicePharmaceutical Research, 1987
- Antitumor agent poly (amino acid) conjugates as a drug carrier in cancer chemotherapy.Journal of Pharmacobio-Dynamics, 1984
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- Glomerular permselectivity: barrier function based on discrimination of molecular size and chargeAmerican Journal of Physiology-Renal Physiology, 1978
- Methotrexate PharmacokineticsJournal of Pharmaceutical Sciences, 1971